Johnson & Johnson (JNJ) is a publicly traded Healthcare sector company. As of July 2, 2026, JNJ trades at $261.25 with a market cap of $611.36B and a P/E ratio of 29.04. JNJ moved +2.84% today. Year to date, JNJ is +22.49%; over the trailing twelve months it is +62.89%. Its 52-week range spans $140.68 to $259.90. Analyst consensus is buy with an average price target of $264.62. Rallies surfaces JNJ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Johnson & Johnson (JNJ) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. JNJ moved +2.84% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $261.25 |
| Market Cap | $611.36B |
| P/E Ratio | 29.04 |
| EPS | $8.73 |
| Dividend Yield | 1.34% |
| 52-Week High | $259.90 |
| 52-Week Low | $140.68 |
| Volume | 473.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $96.36B |
| Net Income | $21.04B |
| Gross Margin | 67.82% |
15 analysts cover JNJ: 0 strong buy, 10 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $264.62.